Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Recruiting1
Not Yet Recruiting1
Unknown1

Clinical Trials (3)

Showing 3 of 3 trials
NCT07649720Not ApplicableNot Yet RecruitingPrimary

NaviCam Patency Capsule to Verify Gastrointestinal Patency

NCT05387031Recruiting

Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease

NCT03886324Not ApplicableUnknownPrimary

POISE I Pilot Study

Showing all 3 trials

Research Network

Activity Timeline